Company Streamlines Product Mix and Targets Consumer Awareness of Hemp vs. Pot

DENVER, CO–Peak Pharmaceuticals, Inc. (OTCQB: PKPH) (“Peak Pharma” or the “Company”), a leading innovator of non-prescription hemp based cannabinoid products, wishes to advise that plans for 2015 summer and fall marketing efforts are underway with a number of initiatives aimed at increasing revenues and growing consumer interest and confidence in its hemp based products.

As part of the Company’s overall growth strategy, an internal program is underway which aims to streamline the company’s supply chain, including its different manufacturing processes, and to boost channel specific marketing efforts. The recently announced plan to introduce Canna-Pet® Advanced120, a new 120mg product designed for medium to large sized dogs, is another component of the efforts to boost the Company’s product offering while delivering an enhanced, second generation Canna-Pet® product that incorporates customer feedback received over the past year.

This consolidation of...